PTH and chronic kidney disease: Pi, acting at residue R62, is a noncompetitive antagonist of the CaSR, and in this respect can be considered an endogenous calcilytic permitting increased PTH secretion with relevance for the physiology of Ca2+ homeostasis and for CKD.